2024 Partners

NanoFCM

NanoFCM

NanoFCM and its leading-edge technology, the NanoAnalyzer, provide a comprehensive solution for high fidelity analysis of thousands of individual EVs. This specialized nano-flow cytometry platform performs label-free measurement of >45nm particles, generating a concentration and size distribution profile with simultaneous sub-population analysis acquired through versatile fluorescent labelling of targets. With the NanoAnalyzer, quantify the proportion of EVs with a given biomarker, an identifier of cell/tissue origin, or those EVs which carry your specific cargo.

RBI_Logo_ForWeb_1200 (002)

Rooster Bio

RoosterBio accelerates human mesenchymal stem cell and exosome product and process development to fuel the rapid implementation of scalable advanced therapies. Our high-quality hMSCs, bioprocess media, genetic engineering tools, and exosome production solutions are paired with expert bioprocessing knowledge to progress therapeutic developers from concept to first-in-human testing and commercial manufacturing under GMP at lower cost and higher productivity. RoosterBio is driven by client success to create a world where safe, effective advanced therapies are rapidly developed on a global scale.